Huch K, Cakir B, Ulmar B, Schmidt R, Puhl W, Richter M
Orthopädische Klinik mit Querschnittgelähmtenzentrum der Universität Ulm/RKU, Ulm.
Z Orthop Ihre Grenzgeb. 2005 Mar-Apr;143(2):213-8. doi: 10.1055/s-2005-836358.
This study analyzes the early and mid-term results of our modular rod-screw implant system for the posterior instrumentation of the occipito-cervical, cervical and cervico-thoracic spine (neon occipito-cervical system, Ulrich, Germany) in patients with tumor osteolysis. The prognosis of the patients was evaluated using the Tokuhashi score.
The cervical and upper thoracic spines of 14 patients (7 males, 7 females, mean age 61 years, range 40-77 years) with osteolysis due to plasmocytoma (n = 2), bronchial (n = 3), mamma (n = 4), thyroid (n = 2), esophageal (n = 1) and pancreatic (n = 1) carcinomas as well as melanoma (n = 1) were instrumentated between June 2001 and April 2004.
A stable fixation without loosening or failure of the fixator system was achieved in all cases. No impairment of the neurological status was observed. In our cohort different prognosis scores failed to make a reliable estimate of the expected survival at the time of surgery.
Posterior instrumentation of the cervical spine including the occipito-cervical and the cervico-thoracic regions with a modular angle-stable rod-screw implant system (neon) offers good stabilization and allows simultaneous decompression. Since tumor masses are predominantly located in the anterior portion of the spine, blood loss can be controlled well. In this patient collective appears difficult to estimate the time of survival by a scoring system.
本研究分析了我们的模块化棒-螺钉植入系统用于肿瘤性骨质溶解患者枕颈、颈椎和颈胸段脊柱后路内固定的早期和中期结果(neon枕颈系统,德国乌尔里希公司)。使用Tokuhashi评分评估患者的预后。
2001年6月至2004年4月期间,对14例因浆细胞瘤(n = 2)、支气管癌(n = 3)、乳腺癌(n = 4)、甲状腺癌(n = 2)、食管癌(n = 1)、胰腺癌(n = 1)以及黑色素瘤(n = 1)导致骨质溶解的患者(7例男性,7例女性,平均年龄61岁,范围40 - 77岁)的颈椎和上胸椎进行了内固定。
所有病例均实现了稳定固定,固定器系统无松动或失效。未观察到神经功能状态受损。在我们的队列中,不同的预后评分未能对手术时的预期生存做出可靠估计。
使用模块化角稳定棒-螺钉植入系统(neon)对包括枕颈和颈胸区域在内的颈椎进行后路内固定可提供良好的稳定性,并允许同时进行减压。由于肿瘤肿块主要位于脊柱前部,失血可得到良好控制。在这个患者群体中,通过评分系统似乎难以估计生存时间。